Insight Communications Company, Inc.

Insight Announces Third Quarter 2008 Results [Press Release]
Business Wire | 10 days 13 hours 52 minutes ago
Insight Communications Company today announced financial and operating results for the quarter ended September 30, 2008.

Insight Announces Second Quarter 2008 Results [Press Release]
Business Wire | 108 days 11 hours 22 minutes ago
Insight Communications Company today announced financial and operating results for the quarter ended June 30, 2008.

CORRECTING and REPLACING Insight Announces Third Quarter 2007 Results [Press Release]
Business Wire | 381 days 16 hours 20 minutes ago
In the financial table titled "Insight Communications Company, Inc.Operating Statistics (in thousands, except per customer and penetration data)" from the press release dated Nov.5, 2007, the figure for Basic Cable Penetration under Q3 2007 should read: 54.

Insight Announces Year-End 2007 Results [Press Release]
Business Wire | 218 days 16 hours 52 minutes ago
Insight Communications Company today announced financial and operating results for the full year ended December 31, 2007.

Insight Announces Second Quarter 2007 Results [Press Release]
Business Wire | 462 days 5 hours 17 minutes ago
Insight Communications Company today announced financial results for the quarter ended June 30, 2007."We couldn't be more pleased with our record second quarter operating and financial results," said Michael Willner, Insight's chief executive officer.

Insight Announces First Quarter 2008 Results [Press Release]
Business Wire | 189 days 9 hours 35 minutes ago
Insight Communications Company today announced financial and operating results for the quarter ended March 31, 2008.

Research and Markets: An Evaluation of Biogen Idec Inc.: Focusing on Performance Forecasts, Key Competitors and Corporate History [Press Release]
Business Wire | 134 days 12 hours 52 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/c65118/biogen_idec_inc) has announced the addition of the "Biogen Idec Inc.: PharmaVitae Profile" company profile to their offering.

The Antithrombotics Market Is Expected To Peak At Just Over $20 Billion In 2012, Across The Seven Major Markets [Press Release]
Business Wire | 360 days 2 hours 22 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c75503) has announced the addition of "Commercial Insight: Antithrombotics - Market Expands as Disease Management Focuses on Prevention" to their offering.

Insight to Announce Second Quarter 2007 Results and Host Conference Call [Press Release]
Business Wire | 463 days 7 hours 21 minutes ago
Insight Communications Company, Inc.will host a conference call to discuss its results for the second quarter ended June 30, 2007, on Friday, August 17, at 10:00 a.m.ET.The conference call will be simultaneously webcast over the Internet as well.

Insight to Announce Third Quarter 2007 Results and Host Conference Call [Press Release]
Business Wire | 392 days 8 hours 50 minutes ago
Insight Communications Company, Inc.will announce its results for the third quarter ended September 30, 2007, on Tuesday, November 6, 2007.Management will subsequently host a conference call at 1:00 p.

The HBV Drugs Market, Sized At $431m In 2006 Across The Seven Major Markets, Will Nearly Triple In Size By 2016 [Press Release]
Business Wire | 360 days 2 hours 22 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c75494) has announced the addition of "Commercial and Pipeline Insight: Hepatitis B" to their offering.Introduction Fuelled by an increasing disease awareness, the growing use of new, expensive drugs as well as combination therapy, the HBV drugs market, sized at $431m in 2006 across the seven major markets, will nearly triple in size by 2016.

Cardiovascular Pipeline Products Are Unlikely To Make A Significant Impact On The Market With Only 16% ($11.9 Billion) Of 2016 Sales Generated From The Current Pipeline [Press Release]
Business Wire | 360 days 2 hours 22 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c75499) has announced the addition of "Commercial Insight: Cardiovascular Market Overview - Raft of Patent Expires Threaten Blockbusters" to their offering.

Research and Markets: See How Amgen Will Suffer as a Consequence of Recent Safety Warnings Concerning Aranesp and Epogen Restricting Their Sales Growth [Press Release]
Business Wire | 254 days 13 hours 6 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c85641) has announced the addition of Amgen Inc.: PharmaVitae Profile to their offering.

Systemic Antifungals: Innovative Approaches Needed to Ensure That Already Costly Trials Do Not Become Prohibitively Expensive [Press Release]
Business Wire | 335 days 11 hours 50 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c78013) has announced the addition of Datamonitor's new report: Commercial and Pipeline Insight: Systemic Antifungals to their offering.Introduction The systemic antifungals market accounts for $3.

Understand Unmet Needs and Opportunities in Pipeline Insight: Substance Dependence - Nicotine Market Based on the Comments of Interviewed Key Opinion Leaders [Press Release]
Business Wire | 336 days 12 hours 49 minutes ago
Research and Markets (http://www.researchandmarkets.com/reports/c77986) has announced the addition of "Pipeline Insight: Substance Dependence - Part I: Nicotine" to their offering.Introduction The high prevalence of nicotine dependence, strong uptake of Pfizer's Chantix (varenicline), and the launch of new innovative therapies will cause the nicotine dependence prescription drug market to grow to $4.